| UniProt ID | KLC2_HUMAN | |
|---|---|---|
| UniProt AC | Q9H0B6 | |
| Protein Name | Kinesin light chain 2 | |
| Gene Name | KLC2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 622 | |
| Subcellular Localization | Cytoplasm, cytoskeleton . | |
| Protein Description | Kinesin is a microtubule-associated force-producing protein that may play a role in organelle transport. The light chain may function in coupling of cargo to the heavy chain or in the modulation of its ATPase activity (By similarity).. | |
| Protein Sequence | MAMMVFPREEKLSQDEIVLGTKAVIQGLETLRGEHRALLAPLVAPEAGEAEPGSQERCILLRRSLEAIELGLGEAQVILALSSHLGAVESEKQKLRAQVRRLVQENQWLREELAGTQQKLQRSEQAVAQLEEEKQHLLFMSQIRKLDEDASPNEEKGDVPKDTLDDLFPNEDEQSPAPSPGGGDVSGQHGGYEIPARLRTLHNLVIQYASQGRYEVAVPLCKQALEDLEKTSGHDHPDVATMLNILALVYRDQNKYKEAAHLLNDALAIREKTLGKDHPAVAATLNNLAVLYGKRGKYKEAEPLCKRALEIREKVLGKFHPDVAKQLSNLALLCQNQGKAEEVEYYYRRALEIYATRLGPDDPNVAKTKNNLASCYLKQGKYQDAETLYKEILTRAHEKEFGSVNGDNKPIWMHAEEREESKDKRRDSAPYGEYGSWYKACKVDSPTVNTTLRSLGALYRRQGKLEAAHTLEDCASRNRKQGLDPASQTKVVELLKDGSGRRGDRRSSRDMAGGAGPRSESDLEDVGPTAEWNGDGSGSLRRSGSFGKLRDALRRSSEMLVKKLQGGTPQEPPNPRMKRASSLNFLNKSVEEPTQPGGTGLSDSRTLSSSSMDLSRRSSLVG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Ubiquitination | MVFPREEKLSQDEIV CCCCCHHHCCCCCCH | 49.00 | 29967540 | |
| 13 | Phosphorylation | FPREEKLSQDEIVLG CCCHHHCCCCCCHHC | 46.80 | 20068231 | |
| 21 | Phosphorylation | QDEIVLGTKAVIQGL CCCCHHCHHHHHHHH | 16.21 | 20068231 | |
| 64 (in isoform 2) | Phosphorylation | - | 24.91 | 29083192 | |
| 97 | Ubiquitination | SEKQKLRAQVRRLVQ HHHHHHHHHHHHHHH | 23.74 | 21890473 | |
| 98 | Phosphorylation | EKQKLRAQVRRLVQE HHHHHHHHHHHHHHH | 23.86 | 32142685 | |
| 100 | Ubiquitination | QKLRAQVRRLVQENQ HHHHHHHHHHHHHCH | 17.71 | 22817900 | |
| 102 | Ubiquitination | LRAQVRRLVQENQWL HHHHHHHHHHHCHHH | 3.06 | 22817900 | |
| 119 | Ubiquitination | ELAGTQQKLQRSEQA HHHHHHHHHHHHHHH | 36.45 | 29967540 | |
| 141 | Phosphorylation | KQHLLFMSQIRKLDE HHHHHHHHHHHHCCC | 18.34 | 20363803 | |
| 145 | Ubiquitination | LFMSQIRKLDEDASP HHHHHHHHCCCCCCC | 63.02 | 29967540 | |
| 151 | Phosphorylation | RKLDEDASPNEEKGD HHCCCCCCCCCCCCC | 40.35 | 29255136 | |
| 163 | Phosphorylation | KGDVPKDTLDDLFPN CCCCCCCCHHHHCCC | 37.91 | 29496963 | |
| 175 | Phosphorylation | FPNEDEQSPAPSPGG CCCCCCCCCCCCCCC | 22.45 | 29743597 | |
| 179 | Phosphorylation | DEQSPAPSPGGGDVS CCCCCCCCCCCCCCC | 37.98 | 29743597 | |
| 186 | Phosphorylation | SPGGGDVSGQHGGYE CCCCCCCCCCCCCCC | 37.16 | 29523821 | |
| 192 | Phosphorylation | VSGQHGGYEIPARLR CCCCCCCCCCCHHHH | 18.44 | 29523821 | |
| 208 | Phosphorylation | LHNLVIQYASQGRYE HHHHHHHHHHCCCCE | 9.33 | 28152594 | |
| 210 | Phosphorylation | NLVIQYASQGRYEVA HHHHHHHHCCCCEEH | 28.38 | 28152594 | |
| 217 | Ubiquitination | SQGRYEVAVPLCKQA HCCCCEEHHHHHHHH | 5.81 | 21890473 | |
| 217 | Ubiquitination | SQGRYEVAVPLCKQA HCCCCEEHHHHHHHH | 5.81 | 33845483 | |
| 220 | Ubiquitination | RYEVAVPLCKQALED CCEEHHHHHHHHHHH | 4.59 | 22817900 | |
| 222 | Ubiquitination | EVAVPLCKQALEDLE EEHHHHHHHHHHHHH | 46.41 | 22817900 | |
| 241 | Ubiquitination | HDHPDVATMLNILAL CCCHHHHHHHHHHHH | 23.26 | 29967540 | |
| 257 | Malonylation | YRDQNKYKEAAHLLN HCCCCCHHHHHHHHH | 42.35 | 26320211 | |
| 292 | Phosphorylation | LNNLAVLYGKRGKYK HHHHHHHHCCCCCCC | 17.63 | 24260401 | |
| 294 | Ubiquitination | NLAVLYGKRGKYKEA HHHHHHCCCCCCCCH | 44.41 | 21906983 | |
| 297 | Ubiquitination | VLYGKRGKYKEAEPL HHHCCCCCCCCHHHH | 58.12 | 22817900 | |
| 299 | Ubiquitination | YGKRGKYKEAEPLCK HCCCCCCCCHHHHHH | 54.67 | 22817900 | |
| 313 | Ubiquitination | KRALEIREKVLGKFH HHHHHHHHHHHHCCC | 53.85 | 29967540 | |
| 318 | Ubiquitination | IREKVLGKFHPDVAK HHHHHHHCCCHHHHH | 36.02 | 29967540 | |
| 328 | Phosphorylation | PDVAKQLSNLALLCQ HHHHHHHHHHHHHHH | 27.57 | 28348404 | |
| 345 | Phosphorylation | GKAEEVEYYYRRALE CCHHHHHHHHHHHHH | 15.80 | 25884760 | |
| 346 | Phosphorylation | KAEEVEYYYRRALEI CHHHHHHHHHHHHHH | 4.13 | 28152594 | |
| 347 | Phosphorylation | AEEVEYYYRRALEIY HHHHHHHHHHHHHHH | 7.85 | 28152594 | |
| 365 | Ubiquitination | LGPDDPNVAKTKNNL CCCCCCCHHHHHCCH | 7.61 | 32142685 | |
| 369 | Ubiquitination | DPNVAKTKNNLASCY CCCHHHHHCCHHHHH | 43.03 | - | |
| 374 | Phosphorylation | KTKNNLASCYLKQGK HHHCCHHHHHHHCCC | 13.37 | 28857561 | |
| 378 | Acetylation | NLASCYLKQGKYQDA CHHHHHHHCCCCCCH | 30.45 | 22424773 | |
| 378 | Ubiquitination | NLASCYLKQGKYQDA CHHHHHHHCCCCCCH | 30.45 | - | |
| 389 | Phosphorylation | YQDAETLYKEILTRA CCCHHHHHHHHHHHH | 17.62 | 27642862 | |
| 390 | Ubiquitination | QDAETLYKEILTRAH CCHHHHHHHHHHHHH | 41.20 | 29967540 | |
| 403 | Phosphorylation | AHEKEFGSVNGDNKP HHHHHHCCCCCCCCC | 20.10 | 20873877 | |
| 428 | Phosphorylation | SKDKRRDSAPYGEYG HCCCCCCCCCCCCCC | 29.36 | 20044836 | |
| 431 | Phosphorylation | KRRDSAPYGEYGSWY CCCCCCCCCCCCHHH | 23.47 | 28796482 | |
| 434 | Phosphorylation | DSAPYGEYGSWYKAC CCCCCCCCCHHHHCC | 16.46 | 28796482 | |
| 436 | Phosphorylation | APYGEYGSWYKACKV CCCCCCCHHHHCCCC | 26.74 | 28796482 | |
| 438 | Phosphorylation | YGEYGSWYKACKVDS CCCCCHHHHCCCCCC | 7.15 | 28796482 | |
| 439 | Methylation | GEYGSWYKACKVDSP CCCCHHHHCCCCCCC | 40.84 | 115972171 | |
| 442 | Ubiquitination | GSWYKACKVDSPTVN CHHHHCCCCCCCCHH | 54.67 | 32142685 | |
| 445 | Phosphorylation | YKACKVDSPTVNTTL HHCCCCCCCCHHHHH | 26.00 | 29255136 | |
| 447 | Phosphorylation | ACKVDSPTVNTTLRS CCCCCCCCHHHHHHH | 30.27 | 22167270 | |
| 450 | Phosphorylation | VDSPTVNTTLRSLGA CCCCCHHHHHHHHHH | 23.91 | 22199227 | |
| 451 | Phosphorylation | DSPTVNTTLRSLGAL CCCCHHHHHHHHHHH | 18.25 | 29396449 | |
| 454 | Phosphorylation | TVNTTLRSLGALYRR CHHHHHHHHHHHHHH | 33.98 | 28555341 | |
| 459 | Phosphorylation | LRSLGALYRRQGKLE HHHHHHHHHHCCCHH | 11.83 | - | |
| 462 | Phosphorylation | LGALYRRQGKLEAAH HHHHHHHCCCHHHCH | 44.36 | 32142685 | |
| 464 | Acetylation | ALYRRQGKLEAAHTL HHHHHCCCHHHCHHH | 34.51 | 25953088 | |
| 470 | Phosphorylation | GKLEAAHTLEDCASR CCHHHCHHHHHHHHC | 27.41 | 28857561 | |
| 479 | Phosphorylation | EDCASRNRKQGLDPA HHHHHCCHHHCCCHH | 31.40 | 32142685 | |
| 480 | Phosphorylation | DCASRNRKQGLDPAS HHHHCCHHHCCCHHH | 52.87 | 32142685 | |
| 487 | Phosphorylation | KQGLDPASQTKVVEL HHCCCHHHHHHHHHH | 43.71 | 25159151 | |
| 499 | Phosphorylation | VELLKDGSGRRGDRR HHHHHCCCCCCCCCC | 38.98 | 26434776 | |
| 505 | Phosphorylation | GSGRRGDRRSSRDMA CCCCCCCCCCCCCCC | 43.11 | 32142685 | |
| 507 | Phosphorylation | GRRGDRRSSRDMAGG CCCCCCCCCCCCCCC | 30.53 | 23927012 | |
| 508 | Phosphorylation | RRGDRRSSRDMAGGA CCCCCCCCCCCCCCC | 30.41 | 23927012 | |
| 512 | Phosphorylation | RRSSRDMAGGAGPRS CCCCCCCCCCCCCCC | 19.98 | 33259812 | |
| 519 | Phosphorylation | AGGAGPRSESDLEDV CCCCCCCCHHHHHHC | 44.58 | 29978859 | |
| 521 | Phosphorylation | GAGPRSESDLEDVGP CCCCCCHHHHHHCCC | 49.06 | 29978859 | |
| 529 | Phosphorylation | DLEDVGPTAEWNGDG HHHHCCCCCCCCCCC | 31.14 | 23186163 | |
| 533 | Phosphorylation | VGPTAEWNGDGSGSL CCCCCCCCCCCCCCC | 30.13 | 32645325 | |
| 537 | Phosphorylation | AEWNGDGSGSLRRSG CCCCCCCCCCCCCCC | 29.92 | 29507054 | |
| 539 | Phosphorylation | WNGDGSGSLRRSGSF CCCCCCCCCCCCCCH | 22.02 | 30576142 | |
| 543 | Phosphorylation | GSGSLRRSGSFGKLR CCCCCCCCCCHHHHH | 32.15 | 30266825 | |
| 545 | Phosphorylation | GSLRRSGSFGKLRDA CCCCCCCCHHHHHHH | 31.88 | 23401153 | |
| 556 | Phosphorylation | LRDALRRSSEMLVKK HHHHHHHCHHHHHHH | 24.98 | 30266825 | |
| 557 | Phosphorylation | RDALRRSSEMLVKKL HHHHHHCHHHHHHHH | 25.80 | 27273156 | |
| 568 | Phosphorylation | VKKLQGGTPQEPPNP HHHHCCCCCCCCCCH | 28.73 | 21815630 | |
| 581 | Phosphorylation | NPRMKRASSLNFLNK CHHHHHHHHHCCCCC | 39.12 | 22167270 | |
| 582 | Phosphorylation | PRMKRASSLNFLNKS HHHHHHHHHCCCCCC | 26.75 | 19664994 | |
| 589 | Phosphorylation | SLNFLNKSVEEPTQP HHCCCCCCCCCCCCC | 33.42 | 23927012 | |
| 594 | Phosphorylation | NKSVEEPTQPGGTGL CCCCCCCCCCCCCCC | 51.15 | 30266825 | |
| 599 | Phosphorylation | EPTQPGGTGLSDSRT CCCCCCCCCCCCCCC | 40.64 | 30266825 | |
| 602 | Phosphorylation | QPGGTGLSDSRTLSS CCCCCCCCCCCCCCC | 34.58 | 27273156 | |
| 604 | Phosphorylation | GGTGLSDSRTLSSSS CCCCCCCCCCCCCCC | 24.64 | 21815630 | |
| 606 | Phosphorylation | TGLSDSRTLSSSSMD CCCCCCCCCCCCCCC | 34.64 | 25159151 | |
| 608 | Phosphorylation | LSDSRTLSSSSMDLS CCCCCCCCCCCCCHH | 27.79 | 23927012 | |
| 609 | Phosphorylation | SDSRTLSSSSMDLSR CCCCCCCCCCCCHHH | 29.55 | 23927012 | |
| 610 | Phosphorylation | DSRTLSSSSMDLSRR CCCCCCCCCCCHHHH | 26.72 | 25159151 | |
| 611 | Phosphorylation | SRTLSSSSMDLSRRS CCCCCCCCCCHHHHH | 20.47 | 23927012 | |
| 612 | Sulfoxidation | RTLSSSSMDLSRRSS CCCCCCCCCHHHHHH | 6.93 | 21406390 | |
| 615 | Phosphorylation | SSSSMDLSRRSSLVG CCCCCCHHHHHHCCC | 22.76 | 23927012 | |
| 618 | Phosphorylation | SMDLSRRSSLVG--- CCCHHHHHHCCC--- | 27.24 | 27273156 | |
| 619 | Phosphorylation | MDLSRRSSLVG---- CCHHHHHHCCC---- | 25.84 | 27273156 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KLC2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KLC2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582 AND SER-610, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445; SER-582 ANDSER-589, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445; SER-582 ANDSER-589, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-507; SER-508 ANDSER-582, AND MASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582, AND MASSSPECTROMETRY. | |